{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:21:05Z","timestamp":1791314465815,"version":"4.3.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Novartis Pharmaceutical, S.A."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02392-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:04:52Z","timestamp":1778738692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal serum and MRI signatures of neuroaxonal injury in high-frequency migraine"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-2007","authenticated-orcid":false,"given":"V\u00edctor J.","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-0267","authenticated-orcid":false,"given":"Edoardo","family":"Caronna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-898X","authenticated-orcid":false,"given":"Joana","family":"Rosell-Mirmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9007-5721","authenticated-orcid":false,"given":"Laila","family":"Asskour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-3769","authenticated-orcid":false,"given":"Deborah","family":"Pareto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2856-4134","authenticated-orcid":false,"given":"Marta","family":"Torres-Ferr\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5296-9401","authenticated-orcid":false,"given":"Alicia","family":"Alpuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-7605","authenticated-orcid":false,"given":"Eul\u00e0lia","family":"Gin\u00e9-Cipr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-9879","authenticated-orcid":false,"given":"Nara","family":"Ikumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-6750","authenticated-orcid":false,"given":"\u00c0lex","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4702","authenticated-orcid":false,"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"2","key":"2392_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 97(2):553\u2013622. https:\/\/doi.org\/10.1152\/physrev.00034.2015 \u00a0PubMed PMID: 28179394","journal-title":"Physiol Rev"},{"issue":"4","key":"2392_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I (2023) Hallmarks of neurodegenerative diseases. Cell 186(4):693\u2013714","journal-title":"Cell"},{"issue":"1","key":"2392_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-020-00612-7","volume":"12","author":"PNE Young","year":"2020","unstructured":"Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A et al (2020) Imaging biomarkers in neurodegeneration: current and future practices. Alzheimers Res Ther 12(1):49","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"2392_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27(6):954\u2013963","journal-title":"Nat Med"},{"issue":"10","key":"2392_CR5","doi-asserted-by":"publisher","first-page":"e70096","DOI":"10.1002\/brb3.70096","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Bai M, Xiong Z, Zhang Q, Wang L, Zeng X (2024) Iron Deposition and Functional Connectivity Differences in Females With Migraine Without Aura: A Comparative Study of Headache Sides. Brain Behav 14(10):e70096","journal-title":"Brain Behav"},{"key":"2392_CR6","doi-asserted-by":"publisher","first-page":"174480692110208","DOI":"10.1177\/17448069211020894","volume":"17","author":"Z Chen","year":"2021","unstructured":"Chen Z, Dai W, Chen X, Liu M, Ma L, Yu S (2021) Voxel-based quantitative susceptibility mapping revealed increased cerebral iron over the whole brain in chronic migraine. Mol Pain 17:17448069211020894","journal-title":"Mol Pain"},{"issue":"1","key":"2392_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1526-4610.2007.00723","volume":"48","author":"W Valfre","year":"2008","unstructured":"Valfre W, Rainero I, Bergui M, Pinessi L (2008) Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 48(1):109\u2013117. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00723.x PubMed PMID: 18184293","journal-title":"Headache"},{"issue":"10","key":"2392_CR8","doi-asserted-by":"publisher","first-page":"E1076","DOI":"10.1212\/WNL.0000000000007047","volume":"92","author":"C Dom\u00ednguez","year":"2019","unstructured":"Dom\u00ednguez C, L\u00f3pez A, Ramos-Cabrer P, Vieites-Prado A, P\u00e9rez-Mato M, Villalba C et al (2019) Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine. Neurology 92(10):E1076\u2013E1085. 101212\/WNL.0000000000007047 PubMed PMID: 30709968","journal-title":"Neurology"},{"issue":"3","key":"2392_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1468-2982.2008.01723.x","volume":"29","author":"MC Kruit","year":"2009","unstructured":"Kruit MC, Launer LJ, Overbosch J, Van Buchem MA, Ferrari MD (2009) Iron accumulation in deep brain nuclei in migraine: A population-based magnetic resonance imaging study. Cephalalgia 29(3):351\u2013359. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01723.x","journal-title":"Cephalalgia"},{"issue":"1","key":"2392_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12916-023-02855-1","volume":"21","author":"X Xu","year":"2023","unstructured":"Xu X, Zhou M, Wu X, Zhao F, Luo X, Li K et al (2023) Increased iron deposition in nucleus accumbens associated with disease progression and chronicity in migraine. BMC Med 21(1):136","journal-title":"BMC Med"},{"issue":"2","key":"2392_CR11","doi-asserted-by":"publisher","first-page":"033310242211447","DOI":"10.1177\/03331024221144783","volume":"43","author":"S Nikolova","year":"2023","unstructured":"Nikolova S, Chong CD, Dumkrieger GM, Li J, Wu T, Schwedt TJ (2023) Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine. Cephalalgia 43(2):03331024221144783","journal-title":"Cephalalgia"},{"key":"2392_CR12","doi-asserted-by":"publisher","unstructured":"Vivero CD, Leira Y, Pi\u00f1eiro MS, Rodr\u00edguez-Osorio X, Ramos-Cabrer P, Mart\u00edn CV et al (2020) Iron deposits in periaqueductal gray matter are associated with poor response to onabotulinumtoxina in chronic migraine. Toxins (Basel) 12(8). https:\/\/doi.org\/10.3390\/toxins12080479 \u00a0PubMed PMID: 32731573","DOI":"10.3390\/toxins12080479"},{"issue":"1","key":"2392_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s10194-022-01526-5","volume":"23","author":"TJ Schwedt","year":"2022","unstructured":"Schwedt TJ, Nikolova S, Dumkrieger G, Li J, Wu T, Chong CD (2022) Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre-and post-treatment with Erenumab. J Headache Pain 23(1):159","journal-title":"J Headache Pain"},{"key":"2392_CR14","doi-asserted-by":"crossref","unstructured":"Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T et al (2024) Neurofilaments as biomarkers in neurological disorders\u2014towards clinical application. Nat Rev Neurol 1\u201319","DOI":"10.1038\/s41582-024-00955-x"},{"issue":"1","key":"2392_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s10194-023-01663-5","volume":"24","author":"LH Overeem","year":"2023","unstructured":"Overeem LH, Raffaelli B, Fleischmann R, S\u00fc\u00dfe M, Vogelgesang A, Maceski AM et al (2023) Serum tau protein elevation in migraine: a cross-sectional case\u2013control study. J Headache Pain 24(1):130","journal-title":"J Headache Pain"},{"issue":"1","key":"2392_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10194-024-01757-8","volume":"25","author":"M S\u00fc\u00dfe","year":"2024","unstructured":"S\u00fc\u00dfe M, Kloetzer C, Strau\u00df S, Ruhnau J, Overeem LH, Bendig M et al (2024) Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study. J Headache Pain 25(1):46","journal-title":"J Headache Pain"},{"issue":"1","key":"2392_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s10194-023-01674-2","volume":"24","author":"J Fang","year":"2023","unstructured":"Fang J, Wu J, Zhang T, Yuan X, Zhao J, Zheng L et al (2023) Serum neurofilament light chain levels in migraine patients: a monocentric case\u2013control study in China. J Headache Pain 24(1):149","journal-title":"J Headache Pain"},{"issue":"3","key":"2392_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neurol.2022.06.010","volume":"179","author":"M Atescelik","year":"2023","unstructured":"Atescelik M, Yilmaz M (2023) Ubiquitin C-terminal hydrolase 1 is increased in migraine attack. Rev Neurol (Paris) 179(3):201\u2013207","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"2392_CR19","doi-asserted-by":"publisher","first-page":"033310242513381","DOI":"10.1177\/03331024251338178","volume":"45","author":"E Gozalov","year":"2025","unstructured":"Gozalov E, Karlsson WK, Christensen RH, Al-Khazali HM, Hansen MB, Olsen DA et al (2025) Serum GFAP and NfL levels in migraine: A registry for migraine (REFORM) study. Cephalalgia 45(5):03331024251338178","journal-title":"Cephalalgia"},{"issue":"8","key":"2392_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1089\/neu.2018.5838","volume":"36","author":"LE Hunter","year":"2019","unstructured":"Hunter LE, Lubin N, Glassman NR, Xue X, Spira M, Lipton ML (2019) Comparing region of interest versus voxel-wise diffusion tensor imaging analytic methods in mild and moderate traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 36(8):1222\u20131230","journal-title":"J Neurotrauma"},{"issue":"4","key":"2392_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3233\/JAD-191078","volume":"74","author":"GM Babulal","year":"2020","unstructured":"Babulal GM, Roe CM, Stout SH, Rajasekar G, Wisch JK, Benzinger TLS et al (2020) Depression is associated with tau and not amyloid positron emission tomography in cognitively normal adults. J Alzheimer\u2019s Disease 74(4):1045\u20131055","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"10","key":"2392_CR22","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C et al (2019) Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92(10):e1007\u2013e1015","journal-title":"Neurology"},{"issue":"2","key":"2392_CR23","doi-asserted-by":"publisher","first-page":"bhae040","DOI":"10.1093\/cercor\/bhae040","volume":"34","author":"Y Ou","year":"2024","unstructured":"Ou Y, Ni X, Gao X, Yu Y, Zhang Y, Wang Y et al (2024) Structural and functional changes of anterior cingulate cortex subregions in migraine without aura: relationships with pain sensation and pain emotion. Cereb Cortex 34(2):bhae040","journal-title":"Cereb Cortex"},{"key":"2392_CR24","doi-asserted-by":"publisher","first-page":"105362","DOI":"10.1016\/j.neubiorev.2023.105362","volume":"153","author":"SH Journ\u00e9e","year":"2023","unstructured":"Journ\u00e9e SH, Mathis VP, Fillinger C, Veinante P, Yalcin I (2023) Janus effect of the anterior cingulate cortex: Pain and emotion. Neurosci Biobehav Rev 153:105362","journal-title":"Neurosci Biobehav Rev"},{"key":"2392_CR25","doi-asserted-by":"publisher","first-page":"117957352312054","DOI":"10.1177\/11795735231205413","volume":"15","author":"BC Chou","year":"2023","unstructured":"Chou BC, Lerner A, Barisano G, Phung D, Xu W, Pinto SN et al (2023) Functional MRI and diffusion tensor imaging in Migraine: a review of Migraine functional and White matter microstructural changes. J Cent Nerv Syst Dis 15:11795735231205412","journal-title":"J Cent Nerv Syst Dis"},{"issue":"9","key":"2392_CR26","doi-asserted-by":"publisher","first-page":"e209305","DOI":"10.1212\/WNL.0000000000209305","volume":"102","author":"RH Christensen","year":"2024","unstructured":"Christensen RH, Ashina H, Al-Khazali HM, Zhang Y, Tolnai D, Poulsen AH et al (2024) Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study. Neurology 102(9):e209305","journal-title":"Neurology"},{"issue":"1","key":"2392_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10194-021-01379-4","volume":"23","author":"J Ren","year":"2022","unstructured":"Ren J, Yao Q, Tian M, Li F, Chen Y, Chen Q et al (2022) Altered effective connectivity in migraine patients during emotional stimuli: a multi-frequency magnetoencephalography study. J Headache Pain 23(1):6","journal-title":"J Headache Pain"},{"key":"2392_CR28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3389\/fneur.2019.01356","volume":"10","author":"M Filippi","year":"2020","unstructured":"Filippi M, Messina R (2020) The chronic migraine brain: what have we learned from neuroimaging? Front Neurol 10:1356","journal-title":"Front Neurol"},{"key":"2392_CR29","doi-asserted-by":"publisher","first-page":"106072","DOI":"10.1016\/j.nbd.2023.106072","volume":"180","author":"L Biscetti","year":"2023","unstructured":"Biscetti L, Cresta E, Cupini LM, Calabresi P, Sarchielli P (2023) The putative role of neuroinflammation in the complex pathophysiology of migraine: from bench to bedside. Neurobiol Dis 180:106072","journal-title":"Neurobiol Dis"},{"issue":"2","key":"2392_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji RR, Nackley A, Huh Y, Terrando N, Maixner W (2018) Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 129(2):343\u2013366","journal-title":"Anesthesiology"},{"key":"2392_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139:136\u2013153","journal-title":"J Neurochem"},{"key":"2392_CR32","doi-asserted-by":"publisher","first-page":"174480692110502","DOI":"10.1177\/17448069211050246","volume":"17","author":"W Dai","year":"2021","unstructured":"Dai W, Liu RH, Qiu E, Liu Y, Chen Z, Chen X et al (2021) Cortical mechanisms in migraine. Mol Pain 17:17448069211050246","journal-title":"Mol Pain"},{"issue":"1","key":"2392_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-022-02525-8","volume":"19","author":"QY Li","year":"2022","unstructured":"Li QY, Chen SX, Liu JY, Yao PW, Duan YW, Li YY et al (2022) Neuroinflammation in the anterior cingulate cortex: the potential supraspinal mechanism underlying the mirror-image pain following motor fiber injury. J Neuroinflammation 19(1):162","journal-title":"J Neuroinflammation"},{"key":"2392_CR34","doi-asserted-by":"crossref","unstructured":"Lei M, Zhang J (2021) Brain function state in different phases and its relationship with clinical symptoms of migraine: an fMRI study based on regional homogeneity (ReHo). Ann Transl Med 9(11)","DOI":"10.21037\/atm-21-2097"},{"key":"2392_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-016-0649-2","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C, Thomas H, Tassorelli C, Katsarava Z, La\u00ednez JM, Lant\u00e9ri-Minet M et al (2016) Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain 17:1\u20139","journal-title":"J Headache Pain"},{"issue":"4","key":"2392_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3988\/jcn.2021.17.4.503","volume":"17","author":"KM Han","year":"2021","unstructured":"Han KM, Ham BJ (2021) How inflammation affects the brain in depression: a review of functional and structural MRI studies. J Clin Neurol 17(4):503","journal-title":"J Clin Neurol"},{"issue":"1","key":"2392_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-024-05964-0","volume":"24","author":"Y Song","year":"2024","unstructured":"Song Y, Jiao H, Weng Q, Liu H, Yi L (2024) Serum neurofilament light chain levels are associated with depression among US adults: a cross-sectional analysis among US adults, 2013\u20132014. BMC Psychiatry 24(1):1\u201311","journal-title":"BMC Psychiatry"},{"issue":"4","key":"2392_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.22292","volume":"69","author":"MS Asghar","year":"2011","unstructured":"Asghar MS, Hansen AE, Amin FM, Van Der Geest RJ, van der Koning P, Larsson HBW et al (2011) Evidence for a vascular factor in migraine. Ann Neurol 69(4):635\u2013645","journal-title":"Ann Neurol"},{"issue":"5","key":"2392_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ana.26472","volume":"92","author":"A Alpuente","year":"2022","unstructured":"Alpuente A, Gallardo VJ, Asskour L, Caronna E, Torres-Ferrus M, Pozo\u2010Rosich P (2022) Salivary CGRP and erenumab treatment response: towards precision medicine in migraine. Ann Neurol 92(5):846\u2013859","journal-title":"Ann Neurol"},{"issue":"1","key":"2392_CR40","doi-asserted-by":"publisher","first-page":"20350","DOI":"10.1038\/s41598-020-76990-7","volume":"10","author":"S Akamine","year":"2020","unstructured":"Akamine S, Marutani N, Kanayama D, Gotoh S, Maruyama R, Yanagida K et al (2020) Renal function is associated with blood neurofilament light chain level in older adults. Sci Rep 10(1):20350","journal-title":"Sci Rep"},{"issue":"8","key":"2392_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00439-023-02575-9","volume":"142","author":"W Zhang","year":"2023","unstructured":"Zhang W, Zhang L, Yang L, Xiao C, Wu X, Yan P et al (2023) Migraine, chronic kidney disease and kidney function: observational and genetic analyses. Hum Genet 142(8):1185\u20131200","journal-title":"Hum Genet"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02392-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:25:35Z","timestamp":1783981535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02392-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02392-1","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved as a phase IV clinical trial by the Vall d\u2019Hebron Ethics Committee (PR(AG)189\/2018) and registered in EudraCT (2019-002224-32). All participants provided written informed consent. Clinical and MRI data were obtained under the trial approval; molecular biomarker analyses were generated under the same ethical framework and participant consent for secondary use of biological samples and data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and patient consent"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship and\/or publication of this article: VJG reports no disclosures. EC has received honoraria from Novartis, Chiesi, Lundbeck, MedScape, Lilly, Teva and Dr. Reddy\u2019s; his salary has been partially funded by R\u00edo Hortega grant Acci\u00f3n Estrat\u00e9gica en Salud 2017\u20132020 from Instituto de Salud Carlos III (CM20\/00217) and Juan Rod\u00e9s fellowship, Subprograma Estatal de Incorporaci\u00f3n de la Acci\u00f3n Estrat\u00e9gica en Salud 2023 (JR23\/00065). He is a junior editor for Cephalalgia. JR-M reports no disclosures; LA reports no disclosures. DP reports no disclosures. MT-F has received honoraria from Allergan-AbbVie, Novartis, Chiesi and Teva. AA has received honoraria from Allergan-AbbVie, Novartis, Chiesi. Gin\u00e9-Cipres E has also received research grants from Sociedad Espa\u00f1ola de Enfermer\u00eda Neurol\u00f3gica. NI reports no disclosures. AR serves\/ed on scientific advisory boards for Novartis, Sanofi-Genzyme, Synthetic MR, TensorMedical, Roche, and Biogen, and has received speaker honoraria from Bayer, Sanofi-Genzyme, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, Bristol-Myers and Biogen, is CMO and co-founder of TensorMedical, and receives research support from Fondo de Investigaci\u00f3n en Salud (PI19\/00950 and PI22\/01589) from Instituto de Salud Carlos III, Spain. PP-R has received, in the last three years, honoraria as a consultant and speaker for: AbbVie, Dr. Reddy\u2019s, Eli Lilly, Lundbeck, Medscape, Novartis, P zer, Organon and Teva. Her research group has received research grants from AbbVie, Novartis and Teva; as well as, Instituto Salud Carlos III, EraNet Neuron, European Regional Development Fund (001-P-001682) under the framework of the FEDER Operative Programme for Catalunya 2014\u20132020 - RIS3CAT; has received funding for clinical trials from AbbVie, Amgen, Biohaven, Eli Lilly, Novartis, Teva. She is the Honorary Secretary of the International Headache Society. She is in the editorial board of Revista de Neurologia. She is an associate editor for Cephalalgia, Headache and Neurologia. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of www.midolordecabeza.org. PPR does not own stocks from any pharmaceutical company.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}